Filing Flows › Abbott Laboratories (ABT) › Free cash flow
Abbott Laboratories (ABT) free cash flow by quarter
Abbott Laboratories' free cash flow was $1.2B in Q3 2026 (third quarter 2026), -39% from Q2 2026. Over the last 7 quarters it ranged from $916M (Q1 2026) to $2.6B (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.2B | -39% | -47% |
| Q2 2026 | $2.0B | +117% | +29% |
| Q1 2026 | $916M | -65% | -2% |
| Q4 2025 | $2.6B | +15% | — |
| Q3 2025 | $2.3B | +48% | — |
| Q2 2025 | $1.5B | +66% | — |
| Q1 2025 | $933M | — | — |
Q3 2026 at a glance
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Abbott Laboratories' free cash flow?
Abbott Laboratories' free cash flow was $1.2B in Q3 2026 (third quarter 2026), -39% from Q2 2026.
How has Abbott Laboratories' free cash flow changed?
Over the last 7 quarters it ranged from $916M (Q1 2026) to $2.6B (Q4 2025).